Recent Price Movement and Market Context
On 16 Dec 2025, Albert David's stock price touched Rs.740.25, the lowest level recorded in the past year. This new low comes after three consecutive sessions of decline, during which the stock has registered a cumulative return of approximately -4.3%. The day’s performance showed a drop of 1.58%, underperforming the Pharmaceuticals & Biotechnology sector by 1.26% on the same day.
The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning indicates a persistent bearish momentum in the short to long term.
In contrast, the broader market index, Sensex, experienced a decline of 248.22 points, or 0.51%, closing at 84,777.39. Despite this fall, Sensex remains 1.63% shy of its 52-week high of 86,159.02 and continues to trade above its 50-day and 200-day moving averages, signalling a relatively more stable market environment compared to Albert David’s stock trajectory.
Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!
- - Just announced pick
- - Pre-market insights shared
- - Tyres & Allied weekly focus
Long-Term Performance and Financial Indicators
Over the past year, Albert David's stock has recorded a return of -47.24%, contrasting sharply with the Sensex’s positive return of 3.68% during the same period. The stock’s 52-week high was Rs.1,448.95, highlighting the extent of the decline to the current low.
Financially, the company has reported negative results for four consecutive quarters. The Profit Before Tax excluding other income (PBT LESS OI) for the latest quarter stands at Rs. -0.44 crore, reflecting a fall of 109.80%. Similarly, the Profit After Tax (PAT) for the quarter is Rs. -3.30 crore, showing a decline of 118.3%. Operating cash flow for the year is also at a low point, recorded at Rs. -28.44 crore.
These figures indicate challenges in profitability and cash generation, which have contributed to the stock’s subdued performance. The company’s operating profit has shown a negative annual growth rate of 244.12% over the last five years, underscoring persistent difficulties in sustaining earnings growth.
Valuation and Risk Considerations
Albert David’s stock is trading at valuations that are considered risky relative to its historical averages. The negative EBITDA and declining profit margins have heightened concerns about the company’s financial health. Over the past year, profits have fallen by 122%, further emphasising the pressure on earnings.
In addition to the recent price decline, the stock has underperformed the BSE500 index over multiple time frames, including the last three years, one year, and three months. This underperformance reflects broader challenges faced by the company in maintaining competitive positioning within the Pharmaceuticals & Biotechnology sector.
On a positive note, the company maintains a low average Debt to Equity ratio of zero, indicating limited reliance on debt financing. Majority ownership remains with promoters, which may influence strategic decisions and capital allocation.
Why settle for Albert David ? SwitchER evaluates this Pharmaceuticals & Biotechnology micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Sector and Market Environment
The Pharmaceuticals & Biotechnology sector, in which Albert David operates, has experienced mixed performance in recent months. While the broader market indices such as Sensex have shown resilience, individual stocks within the sector have faced varying degrees of pressure. Albert David’s current valuation and price movement reflect specific company-level factors rather than sector-wide trends.
Market participants have noted that the stock’s trading below all major moving averages signals a cautious stance among traders and investors. The gap between the current price and the 52-week high of Rs.1,448.95 further illustrates the extent of the stock’s retracement over the past year.
Despite the challenges, the company’s low debt profile and promoter majority ownership remain notable features in its capital structure. These factors may influence future strategic decisions and financial management.
Summary of Key Metrics
To summarise, Albert David’s stock has reached Rs.740.25, its lowest level in 52 weeks, following a three-day losing streak and a year-to-date return of -47.24%. The company’s financial results have shown negative profitability for four consecutive quarters, with operating cash flow at a low point. The stock trades below all significant moving averages and has underperformed both its sector and the broader market indices.
While the broader market, represented by Sensex, remains relatively stable and close to its 52-week high, Albert David’s stock reflects company-specific pressures that have weighed on its valuation and price performance.
Only for Rs. 14,999 - Get Access to 2 Years + 6 Months of All Premium Features on MarketsMojo. As low as ₹500/month! Claim 83% OFF →
